Browse Category

Mergers & Acquisitions 22 December 2025 - 23 December 2025

Warner Bros. Discovery (WBD) Series A Stock Today: Paramount’s $30 Bid Gets Larry Ellison Backstop as Netflix Deal Enters Crunch Time

Warner Bros. Discovery (WBD) Series A Stock Today: Paramount’s $30 Bid Gets Larry Ellison Backstop as Netflix Deal Enters Crunch Time

December 23, 2025 — Warner Bros. Discovery, Inc. Series A common stock traded around $28.98 in U.S. trading on Tuesday, hovering between two competing takeover paths: Netflix’s agreed cash-and-stock combination for WBD’s studios and streaming assets, and Paramount Skydance’s hostile all-cash tender offer for the whole company.
23 December 2025
·····
ServiceNow (NOW) Stock Drops After $7.75 Billion Armis Deal: Today’s News, Analyst Forecasts, and What’s Next (Dec. 23, 2025)

ServiceNow (NOW) Stock Drops After $7.75 Billion Armis Deal: Today’s News, Analyst Forecasts, and What’s Next (Dec. 23, 2025)

ServiceNow, Inc. stock traded lower on Tuesday, December 23, 2025, after the enterprise software leader announced its largest acquisition to date: a $7.75 billion all‑cash agreement to buy cyber exposure management specialist Armis. The move is designed to deepen ServiceNow’s security and risk footprint—especially across operational technology, IoT, and medical devices—at a moment when AI adoption is expanding corporate “attack surfaces” and making cyber governance a board-level priority. ServiceNow Investor Relations+1
23 December 2025
··
Warner Bros. Discovery Stock (WBD) Today: Paramount’s $30 Bid vs. Netflix Deal, Fresh Deal Updates, and Analyst Forecasts (Dec. 23, 2025)

Warner Bros. Discovery Stock (WBD) Today: Paramount’s $30 Bid vs. Netflix Deal, Fresh Deal Updates, and Analyst Forecasts (Dec. 23, 2025)

Warner Bros. Discovery, Inc. stock is trading like a company caught in the gravitational field of two giants—because it is. Shares hovered around $28.89 in Tuesday trading as investors weighed a strengthened hostile bid from Paramount Skydance against Warner Bros. Discovery’s board-backed agreement with Netflix. Reuters
23 December 2025
·····
Clearwater Analytics (CWAN) Stock News Today: $24.55 Take-Private Deal, Latest Forecasts, and What Investors Are Watching (Dec. 23, 2025)

Clearwater Analytics (CWAN) Stock News Today: $24.55 Take-Private Deal, Latest Forecasts, and What Investors Are Watching (Dec. 23, 2025)

Clearwater Analytics Holdings, Inc. stock is trading in deal-mode on December 23, 2025, after the company agreed to be acquired in an all-cash $24.55-per-share transaction led by private equity firms Permira and Warburg Pincus, with support from Francisco Partners and participation from Temasek. Reuters+2SEC+2
23 December 2025
··
Warner Bros. Discovery Stock (WBD) Surges Into a Deal-Driven Crossroads: Netflix Merger, Paramount’s Ellison-Backed Bid, and Wall Street Forecasts (Dec. 23, 2025)

Warner Bros. Discovery Stock (WBD) Surges Into a Deal-Driven Crossroads: Netflix Merger, Paramount’s Ellison-Backed Bid, and Wall Street Forecasts (Dec. 23, 2025)

Warner Bros. Discovery, Inc. is trading less like a traditional media stock and more like a live, headline-powered referendum on which future it gets: a Netflix tie-up for its crown-jewel entertainment assets, or a full-company buyout pitched by Paramount Skydance—now reinforced by a massive personal guarantee from Oracle co-founder Larry Ellison.
23 December 2025
·····
Paramount Skydance Corporation Stock (PSKY): Why Shares Are in Focus on Dec. 23, 2025 as the Company Doubles Down on a Warner Bros. Discovery Bid

Paramount Skydance Corporation Stock (PSKY): Why Shares Are in Focus on Dec. 23, 2025 as the Company Doubles Down on a Warner Bros. Discovery Bid

Paramount Skydance Corporation stock is back in the spotlight on December 23, 2025, after the company sharpened the financing behind its high-profile attempt to acquire Warner Bros. Discovery—and as major shareholders and analysts weigh whether the sweetened terms are enough to change the outcome of one of Hollywood’s most consequential deal fights.
23 December 2025
···
DJT Stock News (Dec. 23, 2025): Trump Media Whiplash Continues After TAE Fusion Merger Surge—What Investors Are Watching Next

DJT Stock News (Dec. 23, 2025): Trump Media Whiplash Continues After TAE Fusion Merger Surge—What Investors Are Watching Next

After a blistering, headline-driven run last week tied to a surprise $6 billion all-stock merger plan with nuclear fusion developer TAE Technologies, DJT abruptly gave back a chunk of those gains—highlighting the stock’s unusual mix of speculation, politics, and now… fusion-energy ambition. Reuters+2SEC+2
23 December 2025
··
Trump Media & Technology Group (DJT) Stock on Dec. 22, 2025: Fusion-Merger Rally Fades, Key Deal Details, and Today’s Forecasts

Trump Media & Technology Group (DJT) Stock on Dec. 22, 2025: Fusion-Merger Rally Fades, Key Deal Details, and Today’s Forecasts

Dec. 22, 2025 — Trump Media & Technology Group Corp. is back in its natural habitat: extreme volatility. After rocketing higher late last week on news of a surprise pivot into nuclear fusion, DJT stock dropped sharply on Monday, Dec. 22, giving back a meaningful portion of those gains. Barron's
22 December 2025
···
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

December 22, 2025 — Warner Bros. Discovery, Inc. Series A Common Stock traded higher Monday as the company’s takeover battle intensified, with Paramount Skydance revising its hostile bid and Netflix disclosing fresh financing arrangements tied to its agreed deal with Warner’s studio-and-streaming assets. Nasdaq+2Reuters+2
22 December 2025
··
Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics (CWAN) Stock Surges on $8.4 Billion Take-Private Deal: Price, Timeline, and What Analysts Are Saying (Dec. 22, 2025)

Clearwater Analytics Holdings, Inc. is in the spotlight on December 22, 2025, after the company confirmed it has agreed to be acquired in an all-cash take-private transaction valued at about $8.4 billion. Shareholders are set to receive $24.55 per share in cash, a headline number that has quickly become the market’s “gravity well” for the stock. Reuters+2CWAN+2
22 December 2025
··
Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics, Inc. stock is no longer trading like a typical biotech momentum name—at least not this week. As of December 22, 2025, the stock is hovering around $14.18, tightly anchored to the $14.50 per-share all-cash buyout BioMarin Pharmaceutical has agreed to pay. Investing.com+1
22 December 2025
···
ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

Dec. 22, 2025 — ProPhase Labs, Inc. is hitting one of the most consequential “inflection points” a micro-cap stock can face: a Nasdaq compliance deadline, a reverse stock split that reshapes how the ticker trades, and a newly announced non-binding reverse merger proposal that could dramatically change what ProPhase Labs is going forward. Reuters+3NASDAQ Trader+3ProPhase Labs, Inc.+3
22 December 2025
··
Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18 on Dec. 22, the market is now pricing FOLD mostly on closing probability and timing, not clinical catalysts. Investing.com+1
22 December 2025
··
Luminar Technologies (LAZR) Stock: Chapter 11 Sale Process, $110M Photonics Deal, and Nasdaq Delisting Countdown (Dec. 22, 2025)

Luminar Technologies (LAZR) Stock: Chapter 11 Sale Process, $110M Photonics Deal, and Nasdaq Delisting Countdown (Dec. 22, 2025)

Updated for Dec. 22, 2025 — Luminar Technologies, Inc. is in the middle of a court-supervised restructuring that has turned the stock into a high-volatility, headline-driven trade. The company filed for Chapter 11 bankruptcy on Dec. 15, lined up a $110 million all-cash deal to sell its photonics subsidiary, and is now facing an imminent Nasdaq delisting—while the share price whipsaws on extraordinary volume. Luminar Technologies, Inc.+2Luminar Technologies, Inc.+2
22 December 2025
····
Eaton Stock (ETN) Week Ahead: Data Center Power Expansion, Boyd Cooling Deal, and Analyst Targets to Watch (Dec. 22–26, 2025)

Eaton Stock (ETN) Week Ahead: Data Center Power Expansion, Boyd Cooling Deal, and Analyst Targets to Watch (Dec. 22–26, 2025)

Eaton Corporation plc heads into the holiday-shortened trading week with investors weighing two competing forces: a powerful multi-year “grid-to-chip” demand story tied to AI data centers and electrification, and near-term questions about valuation, cyclical end-markets, and deal execution.
22 December 2025
···
1 2 3 4 5 … 20
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100
#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100
#3 BUY

Xylem

NYSE: XYL 89 / 100
#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100
#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.